Licensing Partners Novuson possesses a unique Direct Therapeutic Ultrasound technology with potential for licensing or co development with larger medtech OEMs such as Olympus, Stryker, Medtronic, or Boston Scientific. The appointment of an experienced Executive Vice President of Business Development signals a clear push toward market expansion and partner outreach. This creates a strong entry point for strategic licensing, joint development, or distribution deals that leverage established channels while advancing surgical outcome improvements.

Pilot Collaborations Opportunities to run pilot programs or clinical collaborations with hospitals align with the technology's value proposition of improving surgical outcomes. Early clinical engagements can generate real world data to support reimbursement discussions and broader adoption, making Novuson a candidate for hospital partnerships and early access agreements.

Funding Partnerships Funding activity and a history of crowdfunding indicate openness to external capital and strategic investors. With modest revenue today, there is a clear pathway to grow through OEM partnerships, strategic investments, or joint ventures that provide manufacturing scale, regulatory support, and market access.

Regional Growth Regional positioning on the West Coast enables direct engagement with major healthcare networks and KOLs in the Seattle area and beyond. Familiarity with regulatory fundraising processes suggests capabilities to navigate funding and compliance as the company scales toward regulatory milestones and market launch.

Digital Outreach Digital marketing capabilities can support rapid outreach to surgeons, procurement teams, and researchers. A modern tech stack and web presence enable partner portals, inbound lead generation, and demos that accelerate introductions, trials, and potential licensing or distribution discussions.